News

Pharmaceutical Technology10h
UK’s MHRA authorises GSK’s Blenrep for multiple myeloma treatment
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...
Pharmaceutical Technology8h
FDA grants breakthrough status to uniQure’s Huntington’s disease therapy
The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for Huntington's ...
Pharmaceutical Technology12h
Sanofi and Regeneron’s dupilumab approved by FDA for urticaria
Sanofi and Regeneron's Dupixent (dupilumab) has gained approval from the FDA for chronic spontaneous urticaria (CSU) ...